Therapeutic apheresis in autoimmune and rheumatic diseases.
Koo
A P
AP
Departments of Hematology and Medical Oncology, and Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D001781:Blood Component Removal; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003449:Cryoglobulinemia / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D008297:Male; D010951:Plasma Exchange; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D011928:Raynaud Disease / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D014657:Vasculitis / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy